Your Money

If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Email*

Password*

Keep me logged in Forgot your password?

Email*

Bargain Price Stocks for Technology Companies

May 01, 2012

In recent months, investors have been eagerly pursuing shares of Facebook, Groupon, and other hot technology companies.

Target-Date Funds Enable Investors to Own a Diverse Portfolio

February 29, 2012

The fund you should pick depends on your tolerance for volatility. Either aggressive or cautious funds can work. Pick one that suits your temperament.

Conservative Investors, Consumer Companies in a Sluggish Economy

December 01, 2011

Make no mistake: Consumer stocks do not lead the markets every year. During bull markets, investors often ignore consumer goods, which may seem dull compared to technology or finance. But over the long haul, consumer stocks tend to deliver competitive results.

Putting Money Into Mutual Funds

November 01, 2011

Hotel occupancy is improving, and office rents are climbing in strong markets such as New York and Washington, D.C.

Many Japanese Companies Strong Despite Earthquake and Tsunami

August 23, 2011

After the earthquake and tsunami struck Japan, markets sank throughout Asia. Investors worried that the devastation would disrupt power producers and hurt a wide range of manufacturers. But some money managers argue that the pessimism is excessive.

Protect Eroding Nest Eggs

April 18, 2011

Investors worried about inflation should consider owning commodity stocks, including gold, oil, and coal.

Short-Term Bonds Funds, More Yield Without Taking on Much Risk

January 06, 2011

When you shop for an investment, look for short-term funds with steady records. Top performers have long records for making money every year. Plenty of savers are frustrated with the puny yields available on the safest investments.

Short Selling Can Result in Big Profits

November 02, 2010

Plenty of fund investors are frustrated. During the three years ending August 16, the S&P 500 lost 7.4% annually and most funds sank into the red. But a few portfolio managers protected their shareholders by using a technique known as selling short. By taking short positions, managers profit when stocks fall. That has been a recipe for success in erratic markets.

Making Avoiding Poorly-Timed Trades with Track Records

June 18, 2010

In the rollercoaster markets of recent years, many fund investors engaged in self-destructive trading. As markets approached their trough in March 2009, shareholders panicked and began dumping their stock mutual funds.

Examining Your Bond Portfolio

April 01, 2010

Now is a good time to examine your bond portfolio and get ready for the day when rates rise.

Companies with Unique Advantages are Resilient in Downturns

March 02, 2010

Warren Buffett has often talked about investing in companies that are protected by "wide moats." Such businesses dominate their markets for years because of advantages that competitors cannot duplicate.

The Risks and Rewards of Owning Gold

November 23, 2009

Investors incur risks when they own precious metals, but the returns can outpace the S&P 500.

Concentrated Funds Can Be Good Choices

September 18, 2009

To get solid results, pick one with a strong long-term record and then hold on to it for years.

Value Funds That Can Survive the Downturn

July 22, 2009

Financial advisors divide fund managers into two broad categories, growth specialists—those who favor companies with growing earnings—and value seekers—people who aim to buy shares on the cheap.

Picking Companies that Pay Dividends

July 22, 2009

Investors looking for steady payouts should not forget to consider less well-known small stocks.

Looking for High Yields

May 07, 2009

In the arithmetic of the markets, as prices of stocks and bonds fall, yields rise. And with markets in decline, some funds now offer double-digit yields—remarkable payouts at a time when Treasury bonds and many bank certificates of deposit yield well below 5%.

Reopened Funds Could Be a Smart Buy

May 07, 2009

Investors have been dumping mutual funds at a record pace lately, withdrawing $195 billion in the last quarter of 2008, according to the Investment Company Institute, a mutual fund trade group.

Health-Care Sector Relatively Stable

March 17, 2009

Health stocks have long served as defensive holdings—investments that will not collapse in downturns. After all, consumers still buy drugs and visit physicians during recessions. This year some pharmaceutical stocks provided protection, avoiding big losses while almost every other industry sank deeply into the red.

Successful Market-Timing Mutual Funds

February 10, 2009

With the markets in turmoil, plenty of investors are frustrated. Stockholders wish they could sell shares before downturns and buy just as bull markets begin.

Diversification Can Help to Limit Losses

November 01, 2008

Most funds stick to a narrow specialty, such as foreign small stocks or California municipal bonds. But a handful of funds take a different approach, holding broad collections of stocks and bonds.

Your Practice

The move from ICD-9-CM to ICD-10 is enough to strike fear into the hearts of physicians and staff alike. Making the leap from 14,000 codes to almost 69,000, topped with the huge cost to make that change, is understandably daunting.

Read more on
Coping with ICD-10

Have any practice management topics that you'd like us to cover?
Let us know.

Renal Nutrition Update

High Protein Intake May Elevate Levels of Advanced Glycation End Products

Advanced glycation end products (AGEs) are byproducts of non-enzymatic chemical reactions between sugars and amino acids, lipids, or DNA. A wide range of molecules fall into this category.

Our exclusive coverage of Kidney Week 2011 in Philadelphia includes interviews, videos and noteworthy clinical reports.

Sections: Anemia | Transplantation
Secondary Hyperparathyroidism | General News
More: Videos

Commentary

Prostate Cancer Screening: Moving Beyond PSA

The merits of PSA screening have been widely debated due largely to its low specificity for prostate cancer (PCa), especially for high-grade disease.

Expert Q&A

Optimal Sequencing of the New Prostate Cancer Drugs: An Interview with E. David Crawford, MD

Several new drugs have become available for treating advanced prostate cancer in the past year and a half. Dr. Crawford talks to Renal & Urology News about the possible ways in which these drugs might be used.